Genesee Capital Advisors’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
7,460
+903
+14% +$179K 0.49% 41
2026
Q1
$1.08M Sell
6,557
-285
-4% -$49.3K 0.45% 51
2025
Q4
$1.21M Sell
6,842
-1,423
-17% -$237K 0.49% 49
2025
Q3
$1.31M Buy
8,265
+54
+0.7% +$7.97K 0.57% 48
2025
Q2
$1.16M Buy
8,211
+121
+1% +$14.9K 0.52% 51
2025
Q1
$944K Buy
8,090
+507
+7% +$65.3K 0.47% 49
2024
Q4
$953K Sell
7,583
-178
-2% -$21.9K 0.44% 52
2024
Q3
$809K Sell
7,761
-268
-3% -$27K 0.39% 57
2024
Q2
$780K Buy
+8,029
New +$764K 0.38% 59

Other funds holding MS

Genesee Capital Advisors's MS Position: Q2 2026 in Review

Genesee Capital Advisors increased its Morgan Stanley (MS) stake by 14% in Q2 2026, buying an estimated $179K and bringing the position to 7,460 shares worth $1.56M. The position accounts for 0.49% of the portfolio, ranked #41.

Genesee Capital Advisors first reported a position in MS in Q2 2024 and has held it in 9 quarters since. 2,739 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Genesee Capital Advisors held 7,460 shares of Morgan Stanley worth $1.56M as of Q2 2026.
  • Genesee Capital Advisors bought 903 Morgan Stanley shares in Q2 2026, an estimated $179K.
  • Morgan Stanley made up 0.49% of Genesee Capital Advisors's portfolio in Q2 2026, its #41 holding.
  • Genesee Capital Advisors first reported a position in Morgan Stanley in Q2 2024 and has held it in 9 quarters since.
  • 2,739 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Genesee Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.